Adalimumab Biosimilar Adalimumab-adbm and Reference Product Population Pharmacokinetics in Healthy Persons and Patients with Rheumatoid Arthritis to Determine Pharmacokinetic Similarities
Received Date: Jun 02, 2022 / Published Date: Aug 08, 2022
Citation: Ding Y (2022) Adalimumab Biosimilar Adalimumab-adbm and Reference Product Population Pharmacokinetics in Healthy Persons and Patients with Rheumatoid Arthritis to Determine Pharmacokinetic Similarities. J Pharmacokinet Exp Ther 6: 151.
Copyright: © 2022 Ding Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
黑料网 Journals
Article Usage
- Total views: 872
- [From(publication date): 0-2022 - Nov 23, 2024]
- Breakdown by view type
- HTML page views: 688
- PDF downloads: 184